Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

Can these 2 stocks deliver healthy dividends forever?

| Harvey Jones

A dividend stock isn't just for today, it should deliver the goods year after year after year, says Harvey Jones.

Read more »

Investing Articles

Should you buy this stock after it reports a 27% rise in revenue?

| Peter Stephens

Is this company set to soar after positive results?

Read more »

Investing Articles

Forget short-term pain! Buy these FTSE 100 stars for long-term gain

| Royston Wild

Royston Wild looks at two brilliant FTSE 100 (INDEXFTSE: UKX) stocks for long-term investors.

Read more »

Investing Articles

These FTSE 100 beauties are just too cheap to miss!

| Royston Wild

Royston Wild reveals two FTSE 100 (INDEXFTSE: UKX) firecrackers trading far, far too cheaply.

Read more »

Investing Articles

These dividend stocks won’t yield 4%+ forever

| Peter Stephens

Getting a 4%+ yield from these shares beats savings accounts, but may not be available for much longer.

Read more »

Investing Articles

These two FTSE 100 dividends stars still look cheap

| Rupert Hargreaves

These two FTSE 100 (INDEXFTSE: UKX) firms look like safe dividend champions but still appear to be undervalued.

Read more »

Investing Articles

Do these 3 low yielders offer high growth prospects?

| Harvey Jones

A sky-high yield isn't everything these days, is it? Harvey Jones investigates.

Read more »

Investing Articles

Is this a better healthcare buy than AstraZeneca plc after today’s update?

| Peter Stephens

Will this healthcare stock keep beating AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

| Alan Oscroft

Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN)…

Read more »

Investing Articles

These two large caps look seriously undervalued

| Rupert Hargreaves

These two large caps could be the most undervalued in the FTSE 100.

Read more »

Investing Articles

Should you pile into this healthcare stock after today’s update?

| Peter Stephens

Is this healthcare stock a 'must-buy'?

Read more »

Investing Articles

Can you really trust these Footsie big yielders to pay out?

| Royston Wild

Royston Wild discusses the payout prospects of three FTSE 100 dividend stocks.

Read more »